SLS
SELLAS Life Sciences Group, Inc. Common StockstockNASDAQ
At CloseNov 13, 2026 4:00:00 PM EST
7.87USD-1.993%(-0.16)11,170,073
Pre-marketNov 16, 2026 8:03:30 AM EST
7.7463USD-1.447%(-0.1137)
After-hoursNov 13, 2026 4:58:30 PM EST
7.89USD+0.254%(+0.02)
SLS Reddit Mentions by subreddit
Loading…
SLS Mentions × sentiment
Loading…
SLS Specific Mentions latest comments & posts
Please help me understand how SLS which has a market cap of 1,6B$ and pretty much only GPS and a CDK9 inhibitor for AML indication. How can they make money with this? isnt it already overvalued? GPS is used in AML (small cancer indication to start with) only in CR2 non transplantable patient, in the US it s like less than a thousand a year? Am I wrong? Or is its value based on the hope that GPS is usable (and it might be) for other cancer indication in the future?(then prolonging patent and increasing the breadth of treatable patients).
For CDK9 I am really not convinced, CDK inhibitors are historically known to carry major side effects and are very poorly selective. They are notably known for carrying major hematox effect such as myelosupression which is worse in AML than in other cancer due to the nature of the cancer itself messing hematopoiesis. So far, their CDK9 looks safer but still efficacy is questionable due to single arm open label trial and poor CR rate in RR patient in phase1.
So the question is how is this economically viable? It s not frontline breast cancer, it is not a pan KRAS inhibitor, they are dropping a drug for a maximum of few thousands patient a year? Or is all the hope about application in other WT1 positive cancers (but then in this case REGAL 3 is just a proof of concept in a totally different indication)?
Maybe I totally missed something please let me know
sentiment 0.918
ATAI 70% profit. Was my first stock in this area. Now with SLS and DRTS.
sentiment 0.440
SLS +0.19%. How auspicious.
sentiment 0.000
Who is also bullish on $SLS? Phase 3 results this month (probably)!!
sentiment 0.379
Can't wait to clown on SLS bad results this week
sentiment -0.542
I'm about the same as your SLS but with CMPS.
sentiment 0.000
Got $4k+ worth of calls on SLS, this is the best week for readout to come out.
sentiment 0.823
Up over $100k in SLS currently. About to go to $30k (sold some at $15) or $500k.
sentiment 0.064
Aw mAAAAAAAAN i wanted to get some more money on this but im locked with CAPR and SLS lmao
sentiment 0.747
> When you say institutional investors could be wrong, do you mean they already have access to the data? Or are you talking about insider leaks?
I don't mean this at all. What I mean is that hedge funds and other actively managed funds have extremely smart MDs and PhDs on staff who know how to model clinical trial outcomes much better than you and I know how. They will also consult with cancer expert$$ who might help them tune their models in ways that you and I are unaware of. Those experts might tell them how good (or bad) the median OS is for *current* BAT--that's information that you and I don't have. On top of that, they're also probably paying top-dollar for AI models that we can't afford.
If the fact that "REGAL-is-taking-2-years-longer-than-expected" was a clearly positive signal, those MDs and PhDs would be *on it immediately* and they'd be buying $SLS by the truck-load.
But I don't think they are. They're not shorting it, either. Instead, $SLS is kind of neglected/ignored, which says (to me, at least) that the "smart" money thinks REGAL has a chance of success, but it's quite low.
One more comment: years ago, I heard stories of hedge funds trying to track down patients in an important clinical trial and trying to determine if they were on "treatment" or "control" (no idea how they'd do that). I also have no idea if any of that is true, but if it is, I suspect it's rare.
sentiment 0.903
SLS
sentiment 0.000
Love to see the squeeze score on SLS. If Top line is good, that one is going to gap and run.
sentiment 0.836
The straddle is December 4 short the 3 put and short the 15 call, SLS is the company
sentiment -0.459
> Useless comment.
I'm just achieving equality with every breathless $SLS post on this sub.
You guys remind me of little kids getting hyped up for what Santa is bringing them (What's the buy-out gonna be, fellas? $60? $80? Certainly not lower than $40!).
You might find a lump of coal in your stocking.
sentiment 0.376
The run-up thesis assumes the guided news is not already reflected in expectations. If timing or results differ, a calendar catalyst alone may not sustain interest. (Disclosure: I build AimyTrade.) [$SLS research page](https://aimytrade.io/ticker/sls?utm_source=reddit&utm_medium=comment&utm_campaign=biotech_stocks&utm_term=SLS&utm_content=quality-535a5058-e49a-48d6-a07d-1ede23469f67) Has the company specified the update date?
sentiment -0.591
I don't know what a burger take is.
> Contrarian for the sake of being contrarian
Kind of. But the $SLS posts are like an annoying commercial that shows up here over and over and over. It'd be nice to have a greater diversity of "commercials."
> And you don’t hold?
Correct. I keep looking at puts, but they are pricey.
sentiment 0.816
SLS
sentiment 0.000
I’m banned from the main SLS subreddit but wanted to say I appreciate your views there! Just wanted to give a thanks to you.
sentiment 0.771
As a fellow call holder who bought when $SLS was $2, I hope you took some profits, or at least hedged via puts to the downside. Im obviously bullish, but nothing in life is guaranteed
sentiment 0.285
Yes stock was at like $1.80 and these have a break even of just $2.35 lol. Buying options on SLS was money in 2025!
sentiment 0.807
This subreddit is infested with $SLS nonsense I find it annoying enough that I feel compelled to comment.
Let me first state that I think there's a *chance* (albeit low) that REGAL hits.
There's a lot of optimism behind the fact that REGAL has taken far longer to complete than expected.
Obviously, that could be because of strong GPS activity. But that's not guaranteed. If it were guaranteed, you can bet that many smart institutional investors would have already loaded up. That hasn't happened.
Institutional investors *can* be wrong (see Baker Brothers and SMMT this weekend!), but if there's a free penny laying on the ground, they will take it. The delay in completion of REGAL is not a free penny.
As I've said elsewhere, clinical trials are littered with failures where the trial sponsors were surprised by unexpectedly strong control arms.
We will see.
Disclosure. I hold no position in $SLS. I'm thinking about buying some puts, but they're fucking expensive. And I rarely short b/c I don't have the mental fortitude for it.
sentiment -0.211
SLS - Positioned for Phase 3 Readout
sentiment 0.000
I bought a ticket and I’m here for the ride. My only due diligence was with my weed doc. I asked if he knew about SLS, he said “the company with the with the AML treatment? You in? We are gonna be rich.” Then I got some dabs on the way home and bought some shares while the puffco heated up. Fuck cancer.
sentiment -0.233
SLS Regal phase 3 results likely by Thursday and certainly by end of November. Stock will either moon or crash. I am leaning toward the trial being a success and meeting its primary endpoint.
sentiment 0.660
It may as well mint an army of bagholders lol. I have already seen anticipatory copes like SLS has another drug in the pipeline etc.
sentiment 0.751